Compare IOVA & JJSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IOVA | JJSF |
|---|---|---|
| Founded | 2007 | 1971 |
| Country | United States | United States |
| Employees | N/A | 1800 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Specialty Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | 2008 | 1995 |
| Metric | IOVA | JJSF |
|---|---|---|
| Price | $14.29 | $77.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 2 |
| Target Price | $9.00 | ★ $140.00 |
| AVG Volume (30 Days) | ★ 11.4M | 143.2K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 3.67% |
| EPS Growth | ★ 14.84 | N/A |
| EPS | N/A | ★ 1.99 |
| Revenue | N/A | ★ $1,022,038,000.00 |
| Revenue This Year | $47.74 | $0.30 |
| Revenue Next Year | $40.31 | $1.70 |
| P/E Ratio | ★ N/A | $39.07 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.76 | $68.87 |
| 52 Week High | $11.17 | $99.14 |
| Indicator | IOVA | JJSF |
|---|---|---|
| Relative Strength Index (RSI) | 85.96 | 32.95 |
| Support Level | $3.57 | $72.93 |
| Resistance Level | N/A | $78.56 |
| Average True Range (ATR) | 0.67 | 1.92 |
| MACD | 0.27 | -0.42 |
| Stochastic Oscillator | 99.84 | 10.81 |
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.
J&J Snack Foods Corp. manufactures snack foods and distributes frozen beverages, which it markets nationally to the foodservice and retail supermarket industries. The company's portfolio of frozen beverages, frozen novelties, and baked goods includes soft pretzels, frozen juice treats and desserts, stuffed sandwiches, churros, funnel cakes, cookies, and other snack foods and drinks. It operates through three segments: Food Service, which sells snacks, desserts, and baked goods at the point of sale; Retail Supermarkets, which sells frozen and prepackaged products to supermarkets; and Frozen Beverages, which sells frozen beverages under the ICEE, Slush Puppie, and Parrot Ice brands in the United States, Mexico, and Canada. The majority of revenue comes from the Food Service segment.